Related Experiment Video
Updated: Oct 4, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
Subcellular Detection of SARS-CoV-2 RNA in Human Tissue Reveals Distinct Localization in Alveolar Type 2 Pneumocytes
Kofi K Acheampong1, Dylan L Schaff2, Benjamin L Emert3
1Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.
Abstract:
The widespread coronavirus disease 2019 (COVID-19) is caused by infection with the novel coronavirus SARS-CoV-2. Currently, we have limited understanding of which cells become infected with SARS-CoV-2 in human tissues and where viral RNA localizes on the subcellular level. Here, we present a platform for preparing autopsy tissue for visualizing SARS-CoV-2 RNA using RNA fluorescence in situ hybridization (FISH) with amplification by hybridization chain reaction. We developed probe sets that target different regions of SARS-CoV-2 (including ORF1a and N), as well as probe sets that specifically target SARS-CoV-2 subgenomic mRNAs. We validated these probe sets in cell culture and tissues (lung, lymph node, and placenta) from infected patients. Using this technology, we observe distinct subcellular localization patterns of the ORF1a and N regions. In human lung tissue, we performed multiplexed RNA FISH HCR for SARS-CoV-2 and cell-type-specific marker genes. We found viral RNA in cells containing the alveolar type 2 (AT2) cell marker gene (SFTPC) and the alveolar macrophage marker gene (MARCO) but did not identify viral RNA in cells containing the alveolar type 1 (AT1) cell marker gene (AGER). Moreover, we observed distinct subcellular localization patterns of viral RNA in AT2 cells and alveolar macrophages. In sum, we demonstrate the use of RNA FISH HCR for visualizing different RNA species from SARS-CoV-2 in cell lines and FFPE (formalin fixation and paraffin embedding) autopsy specimens. We anticipate that this platform could be broadly useful for studying SARS-CoV-2 pathology in tissues, as well as extended for other applications, including investigating the viral life cycle, viral diagnostics, and drug screening. IMPORTANCE Here, we developed an in situ RNA detection assay for RNA generated by the SARS-CoV-2 virus. We found viral RNA in lung, lymph node, and placenta samples from pathology specimens from COVID patients. Using high-magnification microscopy, we can visualize the subcellular distribution of these RNA in single cells.
Insights
Researchers developed a new RNA detection assay to visualize SARS-CoV-2 RNA in autopsy tissues. This method identified viral RNA in lung, lymph node, and placenta cells, revealing its subcellular distribution in infected cells.
Area of Science:
- Virology
- Pathology
- Molecular Biology
Background:
- The widespread coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2.
- Understanding SARS-CoV-2 cellular tropism and RNA localization is crucial for comprehending COVID-19 pathology.
- Current methods offer limited insight into viral RNA distribution within human tissues at the subcellular level.
Purpose of the Study:
- To develop and validate a platform for visualizing SARS-CoV-2 RNA in autopsy tissues using RNA fluorescence in situ hybridization (FISH) with hybridization chain reaction (HCR) amplification.
- To investigate the subcellular localization of different SARS-CoV-2 RNA species (including subgenomic mRNAs) in infected human tissues.
- To identify specific cell types infected by SARS-CoV-2 in human lung tissue.
Main Methods:
- Development of specific probe sets targeting SARS-CoV-2 RNA regions (ORF1a, N) and subgenomic mRNAs.
- Validation of probe sets in cell culture and formalin-fixed, paraffin-embedded (FFPE) autopsy tissues (lung, lymph node, placenta).
- Application of multiplexed RNA FISH HCR for simultaneous detection of viral RNA and cell-type-specific markers (e.g., SFTPC, MARCO, AGER) in human lung tissue.
Main Results:
- Distinct subcellular localization patterns were observed for different SARS-CoV-2 RNA regions (ORF1a and N).
- Viral RNA was detected in alveolar type 2 (AT2) cells (SFTPC+) and alveolar macrophages (MARCO+) in human lung tissue.
- Viral RNA was not detected in alveolar type 1 (AT1) cells (AGER+).
- Differential subcellular localization of viral RNA was noted in AT2 cells and alveolar macrophages.
Conclusions:
- The developed RNA FISH HCR platform enables visualization of SARS-CoV-2 RNA species in FFPE autopsy specimens.
- This technology provides insights into the subcellular distribution of viral RNA within infected cells.
- The platform is broadly applicable for studying SARS-CoV-2 pathology, viral life cycle, diagnostics, and drug screening.
More Related Videos
07:17Author Spotlight: Studying Spatial Protein Expression Using Agarose Embedded Lung Tissue Sections
Published on: October 6, 2023
09:02Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Published on: September 22, 2023